Glycoproteins of herpes simplex virus type 2 as defined by monoclonal antibodies.
about
Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytes.Effect of acyclovir treatment of primary genital herpes on the antibody response to herpes simplex virusCharacterization of the herpes simplex virus type 1 glycoprotein D mRNA and expression of this protein in Xenopus oocytes.Overlapping T cell antigenic sites on a synthetic peptide fragment from herpes simplex virus glycoprotein D, the degenerate MHC restriction elicited, and functional evidence for antigen-Ia interactionOrientation of the cleavage site of the herpes simplex virus glycoprotein G-2.Identification of C3b-binding regions on herpes simplex virus type 2 glycoprotein CFine mapping of antigenic site II of herpes simplex virus glycoprotein DIdentification of proteins specific for human herpesvirus 6-infected human T cells.Humoral immune response to herpes simplex virus type 2 glycoproteins in patients receiving a glycoprotein subunit vaccine.Synthetic glycoprotein D-related peptides protect mice against herpes simplex virus challengeModification of Epstein-Barr virus replication by tunicamycin.Pathogenicity in mice of herpes simplex virus type 2 mutants unable to express glycoprotein CExpression of herpes simplex virus glycoproteins in polarized epithelial cellsMechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: cytotoxic T cells.Antigenic cross-reactions among herpes simplex virus types 1 and 2, Epstein-Barr virus, and cytomegalovirus.Localization of a type-specific antigenic site on herpes simplex virus type 2 glycoprotein D.Evidence for translational regulation of herpes simplex virus type 1 gD expressionExtensive homology between the herpes simplex virus type 2 glycoprotein F gene and the herpes simplex virus type 1 glycoprotein C gene.Binding to cells of virosomes containing herpes simplex virus type 1 glycoproteins and evidence for fusion.Fine structure analysis of type-specific and type-common antigenic sites of herpes simplex virus glycoprotein DCharacterization of the gene encoding herpes simplex virus type 2 glycoprotein C and comparison with the type 1 counterpartLocalization of epitopes of herpes simplex virus type 1 glycoprotein DIsolation by high-performance liquid chromatography and partial characterization of a 57,000-dalton herpes simplex virus type 1 polypeptide.Cells that constitutively express the herpes simplex virus immediate-early protein ICP4 allow efficient activation of viral delayed-early genes in transIntracellular transport of herpes simplex virus gD occurs more rapidly in uninfected cells than in infected cells.Potent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions.Herpes simplex virus type 2 glycoprotein gF and type 1 glycoprotein gC have related antigenic determinantsCharacterization of a herpes simplex virus type 2 75,000-molecular-weight glycoprotein antigenically related to herpes simplex virus type 1 glycoprotein CInsertion mutants of herpes simplex virus have a duplication of the glycoprotein D gene and express two different forms of glycoprotein D.Mapping of the structural gene for the herpes simplex virus type 2 counterpart of herpes simplex virus type 1 glycoprotein C and identification of a type 2 mutant which does not express this glycoprotein.Mapping of a herpes simplex virus type 2-encoded function that affects the susceptibility of herpes simplex virus-infected target cells to lysis by herpes simplex virus-specific cytotoxic T lymphocytesLimited proteolysis of herpes simplex virus glycoproteins that occurs during their extraction from vero cells.Replication of simian herpesvirus SA8 and identification of viral polypeptides in infected cells.Synthesis and processing of bovine herpesvirus 1 glycoproteins.Synthesis and processing of glycoprotein gG of herpes simplex virus type 2.Kinetics of expression of herpes simplex virus type 1-specific glycoprotein species on the surfaces of infected murine, simian, and human cells: flow cytometric analysis.Characterization of the 92,000-dalton glycoprotein induced by herpes simplex virus type 2.Use of monoclonal antibodies against two 75,000-molecular-weight glycoproteins specified by herpes simplex virus type 2 in glycoprotein identification and gene mapping.Polypeptide specificity of the antibody response after primary and recurrent infection with bovine herpesvirus 1.Identification and typing of herpes simplex virus by enzyme immunoassay with monoclonal antibodies.
P2860
Q33893109-BA03B085-C258-44DF-AB11-29C1E08298F5Q34605155-7D0E0A41-215E-45C6-8470-DDB7469865C0Q35672127-58172294-0C0B-4CEA-9252-BDE2513CDE4EQ36354522-3E7363ED-3201-45C2-AA7D-A1A5CA914E67Q36646404-E6EBF4B3-2955-4C2D-AC1E-0A00CF63F845Q36804841-A8E5B1B1-7376-4D3E-BB00-FEDD11EC1E81Q36827612-18854A6B-5DAB-451A-8287-B851084089F0Q36828858-8976C414-D2E0-486C-B654-CC1C23522C89Q36852943-CF528280-24DB-4858-8A71-B6FC05596E83Q36855019-6B85724B-3FCA-474E-A671-20E773C336C5Q36855590-9B084001-1CFB-41AA-A218-9BB81414F54AQ36860736-EE664A26-4191-421D-91F1-758FCCF0EE74Q36863237-3726B933-51D1-4FD9-B6CD-6E56B7B6FF7DQ36885383-6E94B338-AAF6-4CB8-9D58-B60770C83C14Q36886521-28506819-852F-42DC-9226-5C82951A7D6AQ36892777-9DB1AABE-C673-4902-BEDB-7A8F80319140Q36893360-96669973-59FE-4699-B157-1A84884D7CA7Q36894696-6A91EB62-9C93-479C-8814-4D3EC5EB8092Q36894877-FF76C4D6-B8AA-4C8F-B348-4E54DB797E59Q36895541-9A4166C6-846F-4E69-A81B-3060ECDAD8FAQ36898146-C9CB02DD-E431-4363-A8D5-C891A6088B24Q36898378-BC228947-BC88-498B-9E6F-2936E7312CAFQ36900788-0E7DF686-3657-4BA9-9BB0-EA05B0AAEC6FQ36901175-0519F155-9E98-4AA7-8ACA-FFF459CFD77EQ36901922-021F7C1B-44CF-4196-98E6-1C5B61A4A754Q36903456-E49CE1D6-000C-48A7-A819-B289EB48E989Q36906946-29AB7ED0-87DD-4218-B7D1-3DA5C4F0EA94Q36907968-70B0A6ED-75EE-4007-9043-ED2AA1771BF9Q36909419-6D70CA81-20A4-4A69-A754-B3E660424C3BQ36912927-336B6B23-AC96-4DED-BF6D-A8FDDEC5F66FQ36912992-CD4DBB2B-2E53-4BF1-9A0C-6B65459BBA91Q36914599-354C0405-64DD-4C16-AAB9-C08DD3511A81Q36914986-E05C5779-B22A-4002-892C-ED023F4AD421Q40127224-99047717-E120-4E8A-8404-845001D10EA9Q40135805-95FC0621-01DA-4798-BB47-DE9B7FFBB638Q40137521-06D97EF3-ACE1-4CD4-B7B8-E53728AEF4F7Q40139800-36CBC3E7-6D1C-47FE-A36E-272B3375F481Q40143956-82EE20F3-BB51-4985-B9FE-AA0ABAFFE756Q40205197-C4217BFE-E7A7-4B4D-97E4-8638163DDFD2Q40218857-1299D09E-6AD3-441F-961D-D4921E8FA6AC
P2860
Glycoproteins of herpes simplex virus type 2 as defined by monoclonal antibodies.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
Glycoproteins of herpes simplex virus type 2 as defined by monoclonal antibodies.
@en
type
label
Glycoproteins of herpes simplex virus type 2 as defined by monoclonal antibodies.
@en
prefLabel
Glycoproteins of herpes simplex virus type 2 as defined by monoclonal antibodies.
@en
P2093
P2860
P1433
P1476
Glycoproteins of herpes simplex virus type 2 as defined by monoclonal antibodies.
@en
P2093
Bacchetti S
Balachandran N
P2860
P304
P407
P577
1982-10-01T00:00:00Z